Researchers have discovered a protein that encourages the regrowth of myelin and may lead to new types of treatment for MS in the future
Canadian researchers have presented preliminary results from a clinical study which suggest that surgical treatment to unblock veins draining the brain and spinal cord is not effective in treating MS.
Two recently published studies have reported data on levels of disability in people with MS five years after receiving stem cell transplants.
The full results of the latest ocrelizumab trials have been published in the New England Journal of Medicine.
Babies born with low levels of vitamin D may be more likely to develop multiple sclerosis in later life, according to newly-published research.
The scientific journal Nature has published a supplement focussing on multiple sclerosis research.
Today, a group of MPs and members of the House of Lords has launched a report on the barriers people with MS face to finding and staying in work. The report by the All Party Parliamentary Group for MS makes a series of recommendations on how best to support people with MS in the workplace.
Today the MS Trust publishes the findings of its year-long MS Forward View project, looking at how MS services in the UK can deliver equitable, effective and efficient care for everyone living with MS.
The Scottish Medicines Consortium has announced that fampridine (Fampyra) is not a cost effective treatment for MS-related walking problems.